Hepatitis C Virus
Studies from Duke University provide new data on hepatitis C virus
Published in Hepatitis Weekly, September 7th, 2009
"At 118 sites, patients who had HCV genotype 1 infection and who had not previously been treated were randomly assigned to undergo 48 weeks of treatment with one of three regimens: peginterferon alfa-2b at a standard dose of 1.5 mu g per kilogram of body weight per week or a low dose of 1.0 mu g per kilogram per week, plus ribavirin at a dose of 800 to 1400 mg per day, or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-09-07)
More Articles from Hepatitis Weekly
- Acute Hepatitis
Research from K. Deterding and co-researchers in the area of acute hepatitis described - Baculovirus
Research by J.C. Martyn and colleagues in baculovirus provides new insights - Erythema
Research from A.N. Geria and co-researchers in the area of erythema described - Gene Therapy
Reports from University of California, Medical Department add new data to research in gene therapy - Hepatitis
Research reports from J.R. Larrubia and co-authors provide new insights into hepatitis - Hepatitis A Virus
Researchers from Karolinska University report recent findings in hepatitis A virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
